Target Name: SH2D5
NCBI ID: G400745
Review Report on SH2D5 Target / Biomarker Content of Review Report on SH2D5 Target / Biomarker
SH2D5
Other Name(s): SH2 domain containing 5, transcript variant 1 | SH2D5_HUMAN | SH2 domain-containing protein 5 | SH2 domain containing 5 | SH2D5 variant 1 | SH2 domain-containing protein 5 (isoform 1)

SH2D5: Key Regulator of T-Cell Receptor Function

SH2D5, also known as SH2 domain containing 5, is a protein that plays a crucial role in various cellular processes. It is a key regulator of the T-cell receptor (TCR), which is responsible for cell-mediated immunity. TCR is a transmembrane protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The SH2 domain is a unique feature that is found in the NBD and VR.

SH2D5 is a 21-kDa protein that is expressed in various tissues, including lymphocytes, macrophages, and neurons. It is a glycoprotein that consists of two major domains: the NBD and the SH2 domain. The NBD is a 21-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The NBD is responsible for binding to nucleotides in the TCR. The SH2 domain is another unique feature that is found in the NBD and VR. It is a 25-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The SH2 domain is responsible for binding to the nucleotides in the TCR.

SH2D5 is a critical protein that is involved in the regulation of T-cell receptor (TCR) function. TCR is a transmembrane protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The NBD is responsible for binding to nucleotides in the TCR. The SH2 domain is another unique feature that is found in the NBD and VR. It is a 25-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The SH2 domain is responsible for binding to the nucleotides in the TCR.

SH2D5 is a protein that is expressed in various tissues, including lymphocytes, macrophages, and neurons. It is a glycoprotein that consists of two major domains: the NBD and the SH2 domain. The NBD is a 21-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The NBD is responsible for binding to nucleotides in the TCR. The SH2 domain is another unique feature that is found in the NBD and VR. It is a 25-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The SH2 domain is responsible for binding to the nucleotides in the TCR.

SH2D5 plays a crucial role in the regulation of T-cell receptor (TCR) function. TCR is a transmembrane protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The NBD is responsible for binding to nucleotides in the TCR. The SH2 domain is another unique feature that is found in the NBD and VR. It is a 25-kDa protein that consists of a nucleotide-binding oligomerization domain (NBD), a cytoplasmic domain, and a variable region (VR). The SH2 domain is responsible for binding to the nucleotides in the TCR.

SH2D5 is a protein that is

Protein Name: SH2 Domain Containing 5

Functions: May be involved in synaptic plasticity regulation through the control of Rac-GTP levels

The "SH2D5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SH2D5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

SH2D6 | SH2D7 | SH3 domain-binding protein 1 | SH3BGR | SH3BGRL | SH3BGRL2 | SH3BGRL3 | SH3BP1 | SH3BP2 | SH3BP4 | SH3BP5 | SH3BP5-AS1 | SH3BP5L | SH3D19 | SH3D21 | SH3GL1 | SH3GL1P1 | SH3GL1P2 | SH3GL1P3 | SH3GL2 | SH3GL3 | SH3GLB1 | SH3GLB2 | SH3KBP1 | SH3PXD2A | SH3PXD2A-AS1 | SH3PXD2B | SH3RF1 | SH3RF2 | SH3RF3 | SH3RF3-AS1 | SH3TC1 | SH3TC2 | SH3TC2-DT | SH3YL1 | SHANK1 | SHANK2 | SHANK2-AS1 | SHANK2-AS3 | SHANK3 | SHARPIN | SHB | SHBG | SHC1 | SHC2 | SHC3 | SHC4 | SHCBP1 | SHCBP1L | SHD | SHE | SHF | SHFL | SHH | SHISA2 | SHISA3 | SHISA4 | SHISA5 | SHISA6 | SHISA7 | SHISA8 | SHISA9 | SHISAL1 | SHISAL2A | SHISAL2B | SHKBP1 | SHLD1 | SHLD2 | SHLD2P1 | SHLD2P3 | SHLD3 | SHMT1 | SHMT2 | SHOC1 | SHOC2 | Short transient receptor potential channel (TrpC) | SHOX | SHOX2 | SHPK | SHPRH | SHQ1 | SHROOM1 | SHROOM2 | SHROOM3 | SHROOM4 | SHTN1 | SI | SIAE | SIAH1 | SIAH2 | SIAH3 | Sialidase | Sialyltransferase | SIDT1 | SIDT2 | SIGIRR | SIGLEC1 | SIGLEC10 | SIGLEC11 | SIGLEC12